Healthcare provider profile · identity verified

David James Engstrom, D.O.

Family Practice · LITCHFIELD PARK, AZ · NPI 1710058870

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	539	162
Levothyroxine Sodium	Levothyroxine Sodium	359	108
Lisinopril	Lisinopril	282	84
Amlodipine Besylate	Amlodipine Besylate	255	74
Losartan Potassium	Losartan Potassium	251	81
Rosuvastatin Calcium	Rosuvastatin Calcium	236	78
Metformin Hcl	Metformin Hcl	174	57
Omeprazole	Omeprazole	171	54
Pantoprazole Sodium	Pantoprazole Sodium	160	52
Simvastatin	Simvastatin	146	45
Metoprolol Succinate	Metoprolol Succinate	135	46
Tamsulosin Hcl	Tamsulosin Hcl	130	43
Metformin Hcl Er	Metformin Hcl	112	38
Ozempic	Semaglutide	110	19
Duloxetine Hcl	Duloxetine Hcl	107	29
Pravastatin Sodium	Pravastatin Sodium	101	33
Hydrochlorothiazide	Hydrochlorothiazide	98	29
Gabapentin	Gabapentin	94	37
Mounjaro	Tirzepatide	90	16
Metoprolol Tartrate	Metoprolol Tartrate	79	24
Trazodone Hcl	Trazodone Hcl	79	23
Zolpidem Tartrate	Zolpidem Tartrate	78	24
Escitalopram Oxalate	Escitalopram Oxalate	75	30
Fluticasone Propionate	Fluticasone Propionate	70	33
Albuterol Sulfate Hfa	Albuterol Sulfate	69	35
Prednisone	Prednisone	69	47
Alendronate Sodium	Alendronate Sodium	66	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	16
Sertraline Hcl	Sertraline Hcl	65	19
Tramadol Hcl	Tramadol Hcl	65	17
Trulicity	Dulaglutide	63	13
Bupropion Xl	Bupropion Hcl	60	15
Famotidine	Famotidine	54	18
Pioglitazone Hcl	Pioglitazone Hcl	53	18
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Celecoxib	Celecoxib	52	17
Finasteride	Finasteride	48	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	14
Alprazolam	Alprazolam	46	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	45	45
Meloxicam	Meloxicam	44	16
Carvedilol	Carvedilol	43	15
Atenolol	Atenolol	42	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Glipizide	Glipizide	40	14
Lorazepam	Lorazepam	40	suppressed
Allopurinol	Allopurinol	39	12
Clonazepam	Clonazepam	39	suppressed
Furosemide	Furosemide	39	18
Jardiance	Empagliflozin	39	11
Valsartan	Valsartan	39	11
Doxepin Hcl	Doxepin Hcl	38	16
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	15
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Pregabalin	Pregabalin	36	14
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	17
Synthroid	Levothyroxine Sodium	35	suppressed
Ezetimibe	Ezetimibe	34	14
Nifedipine Er	Nifedipine	34	suppressed
Potassium Chloride	Potassium Chloride	34	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Spironolactone	Spironolactone	33	11
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Eliquis	Apixaban	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Rizatriptan	Rizatriptan Benzoate	30	suppressed
Glimepiride	Glimepiride	29	suppressed
Testosterone	Testosterone	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	22
Ondansetron Odt	Ondansetron	28	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	21
Chlorthalidone	Chlorthalidone	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Azithromycin	Azithromycin	25	20
Diazepam	Diazepam	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	23
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Fluconazole	Fluconazole	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Cephalexin	Cephalexin	21	21
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Naproxen	Naproxen	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Estradiol	Estradiol	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Glyxambi	Empagliflozin/Linagliptin	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Temazepam	Temazepam	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error